This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
p	http://www.wikidata.org/prop/
wikibase	http://wikiba.se/ontology#
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n11	http://dx.doi.org/10.1157/
n12	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q79788870

rdf:type

wikibase:Item

schema:description

наукова стаття, опублікована в січні 2007 artículu científicu espublizáu en xineru de 2007 scientific article published on 01 January 2007 artikull shkencor i botuar më 01 janar 2007 article scientifique (publié 2007) im Jahr 2007 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel

p:P577

wds:Q79788870-2D54C2BA-185D-4850-8428-131EBC8D923B

wdt:P577

2007-01-01T00:00:00Z

p:P2093

wds:Q79788870-F0CD3F55-A79B-4CCE-ABE4-698F4769532C wds:Q79788870-C97BF26C-FCA5-4A59-8FAA-8E2737DFC908 wds:Q79788870-BA503230-7AC7-48E9-9126-01EF784E4D32

wdt:P2093

M C García-Hernández A Romero Casanova P Marco Vera

rdfs:label

[Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department No. 19 of the Valencian Community] [Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department No. 19 of the Valencian Community] [Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department No. 19 of the Valencian Community]

skos:prefLabel

[Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department No. 19 of the Valencian Community] [Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department No. 19 of the Valencian Community] [Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department No. 19 of the Valencian Community]

schema:name

[Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department No. 19 of the Valencian Community] [Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department No. 19 of the Valencian Community] [Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department No. 19 of the Valencian Community]

p:P1476

wds:Q79788870-4857814D-D87E-4248-B981-1B7F71DC7A59

wdt:P1476

[Clinical comments on genetic marker prevalence (factor V Leiden, prothrombin 20210A and homozygous methylenetetrahydrofolate reductase form [Ho-MTHFR]): based on a study conducted in Health Department No. 19 of the Valencian Community]

p:P304

wds:Q79788870-C226EB02-56CC-41FA-8051-433EA269F8A7

wdt:P304

26-28

p:P31

wds:Q79788870-9247A77D-54F5-4974-811E-F31456D53198 wds:Q79788870-0d7353b1-0e99-45af-a7a8-aee62522b02c

wdt:P31

wd:Q7318358 wd:Q13442814

p:P921

wds:Q79788870-0526DB9F-806D-4E12-AB72-F96758FF0A30 wds:Q79788870-FF49CDBF-B941-4DA6-9B01-7BBB4258130B

wdt:P921

wd:Q114049690 wd:Q185986

p:P698

wds:Q79788870-54494C61-87E9-4A49-A428-0EA143DE1D20

wdtn:P698

n12:17306151

wdt:P698

17306151

p:P1433

wds:Q79788870-38756778-797D-4A16-BE72-E99B193404B4

wdt:P1433

wd:Q27713057

p:P433

wds:Q79788870-0F141896-7CDB-4850-B529-83E64CB501E6

p:P478

wds:Q79788870-01163323-3952-4D22-8F11-58C838DCE5C7

wdt:P433

1

wdt:P478

207

p:P356

wds:Q79788870-23742E30-CD55-4C33-9ACB-49B4A39B1093

wdtn:P356

n11:13098497

wdt:P356

10.1157/13098497